US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

295.76

-35.4700-10.71%

Post-market: 295.760.00000.00%19:55 EDT

Volume:530.48K

Turnover:162.52M

Market Cap:583.97M

PE:- -

High:323.00

Open:322.79

Low:294.70

Close:331.23

52wk High:341.93

52wk Low:68.00

Shares:1.97M

Float Shares:1.97M

Volume Ratio:1.45

T/O Rate:26.87%

Dividend:1.03

Dividend Rate:0.35%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Yestar Healthcare Swings to Small Interim Loss Despite Higher Gross Profit

Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy

Ord Minnett Remains a Buy on Sigma Healthcare Ltd (S5YA)

IHH Healthcare Outlook Likely to be Supported by Resilient Patient Demand

AMN Healthcare Services (AMN) After AONL Move Looks Fully Valued Near $35

Simply Wall St.

Sigma Healthcare Ltd (S5YA) Receives a Buy from Morgan Stanley

Ramsay Health Care (RMSYF) Gets a Sell from Morgan Stanley

Memphasys Accelerates Felix Launch After Early Thai FDA Approval

Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV

Health Care Down on Rotation to Tech

Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™

Roivant Sciences Gets FDA Approval for LISRAYA in Dermatomyositis; Shares Rise

MT Newswires Live

Priovant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.

Stryker to participate in the 2026 Wells Fargo Healthcare Conference

Is Sonic Healthcare’s (ASX:SHL) Bigger FY26 Profit And Dividend Reaffirming Or Recasting Its Investment Story?

Simply Wall St.

Replimune Group Lawsuit: Company Asks Court to Dismiss Securities Case Over RP1 FDA Approval Process

Chemed unit claimed to misdiagnose dementia patients, Capitol Forum says

Sector Update: Healthcare

MT Newswires Live

Sigma Healthcare (ASX:SIG) Shares Drift As Margin Compression Tempers Profit Growth

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/LABU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":295.76,"timestamp":1787947200000,"preClose":331.23,"halted":0,"volume":530479,"hourTrading":{"tag":"盘后","latestPrice":295.76,"preClose":295.76,"latestTime":"19:55 EDT","volume":2719,"amount":805526.7898,"timestamp":1787961358839,"change":0,"changeRate":0,"amplitude":0.003466},"delay":0,"changeRate":-0.10708571083537127,"floatShares":1974486,"shares":1974486,"eps":0,"marketStatus":"Market Closed","change":-35.47,"latestTime":"08-28 16:00:00 EDT","open":322.785,"high":323,"low":294.7,"amount":162523074.03118002,"amplitude":0.085439,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":331.23,"sharesOutstanding":3074486,"nav":295.545,"aum":568772231.45,"dividendRate":0.003472,"bidAskSpread":0.002847,"preHourTrading":{"tag":"盘前","latestPrice":323.7,"preClose":331.23,"latestTime":"09:29 EDT","volume":2163,"amount":708605.00781,"timestamp":1787923795309,"change":-7.53,"changeRate":-0.022733,"amplitude":0.034055},"postHourTrading":{"tag":"盘后","latestPrice":295.76,"preClose":295.76,"latestTime":"19:55 EDT","volume":2719,"amount":805526.7898,"timestamp":1787961358839,"change":0,"changeRate":0,"amplitude":0.003466},"volumeRatio":1.445542973311124,"impliedVol":0.9101,"impliedVolPercentile":0.5259},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1974486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.445542973311124,"shares":1974486,"dividePrice":1.0268,"high":323,"amplitude":0.085439,"preClose":331.23,"low":294.7,"week52Low":68,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":295.76,"eps":0,"divideRate":0.003472,"volume":530479,"delay":0,"ttmEps":0,"open":322.785,"prevYearClose":159.39,"prevWeekClose":317.2,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":317.2,"twentyDayClose":227.4,"sixtyDayClose":165.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662061335","title":"Yestar Healthcare Swings to Small Interim Loss Despite Higher Gross Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2662061335","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662061335?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:18","pubTimestamp":1787912288,"startTime":"0","endTime":"0","summary":"Yestar Healthcare Holdings Co Ltd ( ($HK:2393) ) just unveiled an update. Yestar Healthcare reported unaudited interim revenue of RMB661.6 million ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yestar-healthcare-swings-to-small-interim-loss-despite-higher-gross-profit?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yestar-healthcare-swings-to-small-interim-loss-despite-higher-gross-profit?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LABU","BK4588","BK4581","XBI","BK4585","LU0029874061.USD","BK4137","HCSG","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662619610","title":"Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2662619610","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662619610?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:17","pubTimestamp":1787912220,"startTime":"0","endTime":"0","summary":"Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/28/3352601/0/en/teva-announces-proposed-acquisition-of-a-novel-neuroscience-product-reinforcing-disciplined-business-development-approach-under-pivot-to-growth-strategy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","VHT","TCAF","BK4550","NOBL","BK4588","IXJ","CGCV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662056228","title":"Ord Minnett Remains a Buy on Sigma Healthcare Ltd (S5YA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662056228","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662056228?lang=en_us&edition=fundamental","pubTime":"2026-08-28 13:17","pubTimestamp":1787894279,"startTime":"0","endTime":"0","summary":"In a report released today, Tom Godfrey from Ord Minnett maintained a Buy rating on Sigma Healthcare Ltd, with a price target of A$3.40. According ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ord-minnett-remains-a-buy-on-sigma-healthcare-ltd-s5ya-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ord-minnett-remains-a-buy-on-sigma-healthcare-ltd-s5ya-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4137","LU0029874061.USD","BK4581","LABU","LU0128526141.USD","BK4585","HCSG","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662535520","title":"IHH Healthcare Outlook Likely to be Supported by Resilient Patient Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2662535520","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662535520?lang=en_us&edition=fundamental","pubTime":"2026-08-28 11:27","pubTimestamp":1787887620,"startTime":"0","endTime":"0","summary":"0327 GMT - IHH Healthcare's near-term growth prospects are supported by resilient demand for quality healthcare, improving patient numbers and ongoing capacity expansion, Public Investment Bank says in a note. Growth in its Malaysia business should remain supported by medical tourism and same-day medical procedures, it says. Its Singapore business is expected to recover in 2H as hospital occupancy and margins improve, it adds. Public Investment Bank maintains its rating on IHH at outperform and its target price at 11.43 ringgit. Shares are 1.0% higher at 8.23 ringgit.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCSG","XLV","BK4588","BK4581","XBI","LABU","BK4585","LU0029874061.USD","LU0128526141.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662605557","title":"AMN Healthcare Services (AMN) After AONL Move Looks Fully Valued Near $35","url":"https://stock-news.laohu8.com/highlight/detail?id=2662605557","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662605557?lang=en_us&edition=fundamental","pubTime":"2026-08-28 11:25","pubTimestamp":1787887548,"startTime":"0","endTime":"0","summary":"AMN Healthcare Services (AMN) recently joined the AONL Foundation Corporate Advisory Council, aligning its nursing leadership efforts with the company’s expansion into technology enabled workforce platforms and automation, which are influencing investor attention.\nOver the past year, AMN Healthcare Services has seen a sharp shift in sentiment, with the share price climbing strongly, including a 21.09% 90 day share price return and 132.01% year to date share price return. The 1 year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-amn/amn-healthcare-services/news/amn-healthcare-services-amn-after-aonl-move-looks-fully-valu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-amn/amn-healthcare-services/news/amn-healthcare-services-amn-after-aonl-move-looks-fully-valu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4196","BK7095","XLV","AMN","XBI","AMN.AU","BK4581","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662037042","title":"Sigma Healthcare Ltd (S5YA) Receives a Buy from Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2662037042","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662037042?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:35","pubTimestamp":1787880935,"startTime":"0","endTime":"0","summary":"In a report released today, Melinda Baxter from Morgan Stanley maintained a Buy rating on Sigma Healthcare Ltd, with a price target of A$3.30. Acco...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/sigma-healthcare-ltd-s5ya-receives-a-buy-from-morgan-stanley-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/sigma-healthcare-ltd-s5ya-receives-a-buy-from-morgan-stanley-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4588","XLV","LABU","LU0128526141.USD","XBI","BK4581","BK4137","HCSG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662020037","title":"Ramsay Health Care (RMSYF) Gets a Sell from Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2662020037","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662020037?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:35","pubTimestamp":1787880929,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst David Bailey maintained a Sell rating on Ramsay Health Care today and set a price target of A$40.90. According to TipRanks, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-gets-a-sell-from-morgan-stanley-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-gets-a-sell-from-morgan-stanley-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","BK4588","BK4185","RMSYF","BK4585","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662031640","title":"Memphasys Accelerates Felix Launch After Early Thai FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2662031640","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662031640?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:18","pubTimestamp":1787872720,"startTime":"0","endTime":"0","summary":"Memphasys Ltd ( ($AU:MEM) ) has provided an update. Memphasys Limited has secured early approval from the Thai Food and Drug Administration for its...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/memphasys-accelerates-felix-launch-after-early-thai-fda-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/memphasys-accelerates-felix-launch-after-early-thai-fda-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEM","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036059","title":"Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036059","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036059?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:55","pubTimestamp":1787867719,"startTime":"0","endTime":"0","summary":"Gilead (GILD) Sciences announced that the FDA approved Bixlenvo – bictegravir 75 mg/lenacapavir 50 mg -, the smallest once-daily single tablet regi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gileads-bixlenvo-approved-by-fda-for-virologically-suppressed-adults-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gileads-bixlenvo-approved-by-fda-for-virologically-suppressed-adults-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU2324357040.USD","LU1934455194.USD","LU1023059063.AUD","LU0122379950.USD","IBB","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","LU1066053197.SGD","LU1674673428.USD","LU1934455863.HKD","LU1571399168.USD","LU0234570918.USD","BIB","SG9999015945.SGD","BMED","LU1037948897.HKD","TMED","LU1839511570.USD","IBBQ","BBH","SG9999015986.USD","LU1585245621.USD","TBXU","BK4583","BK4139","BK4585","BK4566","BK4568","LU0889565916.HKD","LU0965509101.SGD","LU1061106388.HKD","LU1057294990.SGD","LU2087621335.USD","LU0859254822.USD","LU0823416689.USD","BK4588","LU0965509283.SGD","GILD","BK4532","LU2357627491.SGD","LU0058720904.USD","LU1066051498.USD","IE00B19Z3581.USD","LU0861579265.USD","MEDI","IE00B19Z3B42.SGD","LU1674673691.USD","SG9999015952.SGD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662603529","title":"Health Care Down on Rotation to Tech","url":"https://stock-news.laohu8.com/highlight/detail?id=2662603529","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662603529?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:26","pubTimestamp":1787865960,"startTime":"0","endTime":"0","summary":"Health-care companies fell as traders rotated out of defensive sectors back into the high-risk tech sector.Novo Nordisk shares slipped after analysts at brokerage Deutsche Bank cut their rating on the Ozempic maker, warning that a recent deceleration in sales growth could continue. Intensified competition from Eli Lilly and smaller rivals has weighed on the Danish giant's earnings in recent quarters, as it gives up some of its early lead on the wildly popular GLP-1 category of drugs.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4585","XLV","XBI","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662112039","title":"Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™","url":"https://stock-news.laohu8.com/highlight/detail?id=2662112039","media":"GlobeNewswire","labels":["executive","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662112039?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:05","pubTimestamp":1787861100,"startTime":"0","endTime":"0","summary":"Kevin Lundquist   Kevin Lundquist  Seasoned finance executive brings more than 20 years of leadership experience across global commercial organizations, including the pharmaceutical and medical techno","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3352397/0/en/outlook-therapeutics-appoints-kevin-lundquist-as-chief-financial-officer-as-it-prepares-for-u-s-commercial-launch-of-lytenava.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XNTK","SMH","SGXZ81514606.USD","CHAT","AMUU","PSI","AMDG","LU2896262040.SGD","LENZ","AMDU","SOXY","SOXX","AMDY","CHPS","GAMR","LEGR","BAI","AMDS","AIQ","DAMD","AMDD","LU0127658192.USD","FTXL","BK4512","AMDC","QQQA","ARTY","SAMD0main","AMDL","FAI","AMD","IETC","WUGI","AMYY","ILDR","LU0133085943.USD","TEK","IEIH","TTEQ","USXF","SMHX","LU1852331112.SGD","AIS","SGXZ51526630.SGD","LABU","WISE","CNAV","TRFK","AMDW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662003883","title":"Roivant Sciences Gets FDA Approval for LISRAYA in Dermatomyositis; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2662003883","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662003883?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:58","pubTimestamp":1787860715,"startTime":"0","endTime":"0","summary":"Roivant Sciences (ROIV) said Thursday the FDA approved LISRAYA for adults with dermatomyositis, with the once-daily pill now available in the US, sending its shares up 1.5%.The approval follows the Ph","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4585","BK4007","ROIV","PTH","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662008070","title":"Priovant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2662008070","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662008070?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:28","pubTimestamp":1787858880,"startTime":"0","endTime":"0","summary":"LISRAYA represents the first major therapeutic innovation in decades for adults with dermatomyositis (DM), a debilitating systemic autoimmune diseaseLISRAYA is a once-daily pill that directly targets ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3352364/34323/en/priovant-announces-fda-approval-of-lisraya-brepocitinib-for-adults-with-dermatomyositis-now-available-in-the-u-s.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","MACE","BK4157","BK4585","RA","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662080831","title":"Stryker to participate in the 2026 Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662080831","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662080831?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:00","pubTimestamp":1787857200,"startTime":"0","endTime":"0","summary":"Portage, Michigan, Aug.  27, 2026  -- Stryker  will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at the Encore Boston Harbor. Preston Wells, Vice President, Chief Financial Officer and Nick Mead, Vice President, Investor Relations will also participate in a fireside chat session at 2:15 p.m. . A simultaneous live audio webcast and replay of the session can be accessed atStryker - Events & Presentations. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com. Contacts For investor inquiries:Nick Mead, Vice President, Investor Relations at 269-385-2600 or nick.mead@stryker.com  For medi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3352354/0/en/stryker-to-participate-in-the-2026-wells-fargo-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","HCSG","LABU","LU0211328371.USD","LU2089984988.USD","LU1035773651.USD","LU0128525689.USD","XBI","LU0029864427.USD","LU1791710582.SGD","BK4581","LU0310799852.SGD","GB00B4QBRK32.GBP","LU0211327993.USD","LU0106831901.USD","BK4559","LU0128525929.USD","LU0128526141.USD","LU2506952097.USD","LU0640476718.USD","LU1280957306.USD","KBWB","LU2324357040.USD","LU0058720904.USD","LU1791807156.HKD","LU1791710400.SGD","LU1668664300.SGD","LU0477156953.USD","SYK","WFC","LU1267930227.SGD","LU0052756011.USD","BK4582","XLV","LU0980610538.SGD","FTXO","IYF","IE0002270589.USD","LU1506573853.SGD","IHI","LU0787776722.HKD","LU0070302665.USD","LU0690374961.EUR","LU0130102774.USD","LU0868494708.USD","LU1267930573.SGD","TFNS","LU0289960550.SGD","LU0432979614.USD","PGF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662033368","title":"Is Sonic Healthcare’s (ASX:SHL) Bigger FY26 Profit And Dividend Reaffirming Or Recasting Its Investment Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662033368","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662033368?lang=en_us&edition=fundamental","pubTime":"2026-08-28 02:39","pubTimestamp":1787855940,"startTime":"0","endTime":"0","summary":"Sonic Healthcare Limited has released its full-year results for the year ended June 30, 2026, reporting revenue of A$10.97 billion, net income of A$608.29 million and declaring a semi-annual dividend of A$0.63 per share, payable on September 17, 2026.\nThe combination of higher sales and earnings compared with the prior year and the confirmed dividend suggests the company is emphasizing both growth and ongoing cash returns to shareholders.\nNow we will examine how this higher full-year revenue...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-shl/sonic-healthcare-shares/news/is-sonic-healthcares-asxshl-bigger-fy26-profit-and-dividend","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-shl/sonic-healthcare-shares/news/is-sonic-healthcares-asxshl-bigger-fy26-profit-and-dividend","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AIPO","DECU","SHL.AU","BK4585","BK7124","FEBU","BK4588","BK4581","GXDW","VGFPF","RGLO","JOYT","XLV","XBI","LABU","VOTE","PMDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662120082","title":"Replimune Group Lawsuit: Company Asks Court to Dismiss Securities Case Over RP1 FDA Approval Process","url":"https://stock-news.laohu8.com/highlight/detail?id=2662120082","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662120082?lang=en_us&edition=fundamental","pubTime":"2026-08-28 01:35","pubTimestamp":1787852158,"startTime":"0","endTime":"0","summary":"Replimune Group, Inc. (NASDAQ: REPL) and several current or former company leaders have asked a federal court in Massachusetts to dismiss an invest...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/replimune-group-lawsuit-company-asks-court-to-dismiss-securities-case-over-rp1-fda-approval-process?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/replimune-group-lawsuit-company-asks-court-to-dismiss-securities-case-over-rp1-fda-approval-process?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNQmain","QQQY","GPIQ","SQQQ","TQQY","JEPQ","REPL","ONEQ","TQQQ","QQQM","QQQE","NDX","BK4139","BK4585","QLD","TECS",".IXIC","BK4588","QQQ","FTEC","PSQ","QQQJ","QID","IYW","QYLG","QDTE","NQmain","QQQA","NVIW.SI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662111082","title":"Chemed unit claimed to misdiagnose dementia patients, Capitol Forum says","url":"https://stock-news.laohu8.com/highlight/detail?id=2662111082","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662111082?lang=en_us&edition=fundamental","pubTime":"2026-08-28 01:35","pubTimestamp":1787852110,"startTime":"0","endTime":"0","summary":"The Capitol Forum stated in a post to X: “Chemed (CHE): Vitas Healthcare Misdiagnosed Dementia Patients and ‘Fudged’ Evaluation Scores in Order to ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/chemed-unit-claimed-to-misdiagnose-dementia-patients-capitol-forum-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/chemed-unit-claimed-to-misdiagnose-dementia-patients-capitol-forum-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","IE00BLDYK493.USD","BK4179","LU1620156130.USD","LU1596574779.USD","CHE","LU2413666004.HKD","BK4588","LU1721427968.SGD","XBI","LU1620156213.USD","LU1543694498.USD","SOCL","LABU","FET","LU1165135440.EUR","XLV","BK4581","BK4585","LU2413665964.HKD","IE00B64QTZ34.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662017084","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2662017084","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662017084?lang=en_us&edition=fundamental","pubTime":"2026-08-28 01:03","pubTimestamp":1787850204,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Thursday afternoon, with the NYSE Healthcare Index decreasing 0.8% and the State Street Health Care Select Sector SPDR ETF  shedding 0.7%.The iShares Biotechnology ETF  was fractionally lower.In corporate news, Moderna  shares fell 5.6% after it said Thursday it plans to offer $2 billion worth of convertible senior notes due 2032 in a private placement.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MRNA","BK4551","GNOM","BK4585","MRNY","LGHT","BK4581","LU0128526141.USD","BK4532","BK4501","BK4548","LABU","FDN","BK4139","BK4588","BK4533","BK4137","STT","MRNX","XBI","BK4568","LU0029874061.USD","HCSG","XLV","BK4534","IBB","IDNA","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662808465","title":"Sigma Healthcare (ASX:SIG) Shares Drift As Margin Compression Tempers Profit Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662808465","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662808465?lang=en_us&edition=fundamental","pubTime":"2026-08-27 23:40","pubTimestamp":1787845258,"startTime":"0","endTime":"0","summary":"Sigma Healthcare stock closed at A$2.62, with the shares drifting over the past month even as the company posted one of the stronger profit stories in Australian healthcare retail this season. The headline is simple: normalised net profit after tax reached A$732 million and normalised earnings per share came in at A$0.064, backed by a A$0.04 full year dividend.\nThe short term price softness now sits against a business that has lifted earnings faster than revenue and is running a trailing net...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-sig/sigma-healthcare-shares/news/sigma-healthcare-asxsig-shares-drift-as-margin-compression-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-sig/sigma-healthcare-shares/news/sigma-healthcare-asxsig-shares-drift-as-margin-compression-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4581","BK7103","XBI","BK4588","SIG.AU","LABU","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662813780","title":"Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662813780","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662813780?lang=en_us&edition=fundamental","pubTime":"2026-08-27 23:20","pubTimestamp":1787844046,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Verrica Pharmaceuticals (VRCA) and Amgen (AMGN). Verrica Pharmace...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-verrica-pharmaceuticals-vrca-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-verrica-pharmaceuticals-vrca-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1023059063.AUD","LU0109394709.USD","TBXU","IE0009355771.USD","VRCA","BK4139","BK4007","LU2089984988.USD","IE00BJT1NW94.SGD","PBE","LU2242646821.SGD","IBBQ","LU0868494617.USD","LU1057294990.SGD","LU0289739699.SGD","LU0889565916.HKD","BIB","BK4599","HCSG","BK4137","IE0002141913.USD","BK4566","IE00B4R5TH58.HKD","BK4581","LU2242652126.USD","LU2112291526.USD","IE00B2B36J28.USD","LU0128526141.USD","LU1061106388.HKD","LU0122379950.USD","BK4534","PJP","IE00BFTCPJ56.SGD","BK4533","BBH","AMGN","IE00BJJMRZ35.SGD","XBI","IBB","LU1571399168.USD","LU0029874061.USD","LU0058720904.USD","SG9999001440.SGD","XLV","LU0320765992.SGD","LU1983299246.USD","BK4585","LU2468319806.SGD","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":3,"totalSize":399,"code":"91000000","status":"200"}]}}